Stock Region Penny Picks - Sunday, October 13th, 2024
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult with a financial advisor before making investment decisions.
$TPST - Tempest Therapeutics

Tempest has announced a significant agreement with Roche to advance their Amezalpat combination therapy into a pivotal trial for first-line hepatocellular carcinoma. This partnership could expedite Tempest's entry into a highly competitive market.
$YYAI - Yuanyu AI

Yuanyu is making waves by entering the $4 billion matchmaking industry, backed by a substantial $30 million licensing agreement. This move positions Yuanyu for potential growth in a burgeoning sector.
$CMND - Clearmind Medicine

Clearmind Medicine has received IRB approval for its FDA first-in-human clinical trial of CMND-100 at a second clinical site. This approval marks a critical step forward in their clinical development strategy.
$APLD - Applied Digital
Craig-Hallum has maintained a "Buy" rating on Applied Digital, with an increased price target of $12. The company's strategic initiatives may bolster its market position and appeal to growth-focused investors.
$DTSS - Datasea
Datasea is projecting a significant revenue increase of approximately $22.7 million for the first quarter of the 2025 fiscal year, representing a year-over-year growth of 230%. This forecast suggests a robust upward trajectory.
$BSFC - Blue Star Foods
Blue Star Foods' Taste of BC Aquafarms has secured a fingerling supply agreement with Miracle Springs, setting the stage for accelerated growth. This agreement could enhance their operational capacity and market reach.
$NIVF - NIVF TW Opportunities Master Fund II, L.P.
NIVF has disclosed a 9.9% passive stake in the company, with a noticeable volume spike at 0.81. This investment reflects increased interest and potential influence on company decisions.
$BTTR - Better Choice Company
Better Choice Company plans to expand into veterinary medicine in 2025 following its acquisition of SRx Health. This strategic expansion could diversify its revenue streams and market presence.
$AGBA - AGBA Group
AGBA is progressing towards the completion of its merger with Triller, which could unlock new growth avenues and synergies, enhancing shareholder value.
$TWG - Top Wealth Group Holding Limited
Top Wealth Group has announced a $10.8 million public offering of ordinary shares. This offering might provide the capital needed to support its growth strategy.
$CDT - AstraZeneca
AstraZeneca has reported a 9.9% stake in the company, as filed in a 13G. This significant stake signals confidence in CDT's potential and strategic direction.
$DUO - FangDD
FangDD has regained compliance with Nasdaq's minimum bid price requirement, stabilizing its listing status and potentially restoring investor confidence.
$ALCE - ALCE
Following a reverse stock split, ALCE is trading at 2.72. The company recently improved its shareholder equity position by shedding $100 million in debt and payables.
$VERB - Verb Technology Company
The CEO of Verb Technology, in a recent shareholder letter, highlighted the company's strong cash position and implied that the stock is undervalued, suggesting a potential buying opportunity.
$GSIW - GSIW Holdings

Oriental Moon Tree has taken a 68% stake in GSIW, as filed in a 13D at a current price of 1.81. This majority stake could lead to strategic shifts in the company's operations.
$DWTX - Virios Therapeutics, Inc.

Virios Therapeutics and Wex Pharmaceuticals have announced a business combination. This merger could enhance their market footprint and operational capabilities.
$TVGN - Tevogen Bio

Tevogen Bio plans to reveal the $1B+ revenue potential of its pipeline portfolio starting the week of October 14, 2024. This announcement could signify substantial growth opportunities.
Disclaimer: The information provided in this newsletter is subject to change and should be verified independently. Stock Region is not responsible for any investment decisions made based on this information.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net